Disulfidptosis-based molecular clustering and prognostic signatures predict patient survival and the immune landscape in patients with colon cancer
The prognostic features based on 10 PRDEGs performed well in predicting survival, TME status, and response to immunity in COAD patients, helping provide personalized immunotherapy strategies for patients.
Authors
- Xueqing Yao (ORCID: https://orcid.org/0000-0003-0570-7585)
- Ge Wen (ORCID: https://orcid.org/0000-0003-4460-0991)
- Junjiang Wang (ORCID: https://orcid.org/0000-0003-0097-9346)
- Yongli Ma (ORCID: https://orcid.org/0000-0003-3060-7295)
- Si Wen (ORCID: https://orcid.org/0000-0002-5115-0696)
- Liang Wen
- Jinghui Li (ORCID: https://orcid.org/0000-0003-2193-1288)
- Guosheng Zhang (ORCID: https://orcid.org/0009-0005-6367-6627)
- Ji-zhen Guo
- Chengzhi Huang (ORCID: https://orcid.org/0000-0002-4680-0578)
- Dengzhuo Chen
- Ping Wang (ORCID: https://orcid.org/0009-0003-1618-262X)
Institutions
- Ganzhou People's Hospital (CN)
- Gannan Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1007/s12672-025-02142-w
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China